Published in Ann Surg on July 01, 1998
ReCAP: Serum Tumor Marker Use in Patients With Advanced Solid Tumors. J Oncol Pract (2015) 2.01
Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ (2004) 1.41
Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer (2013) 1.21
Surgical resection of stage IV colorectal cancer and prognosis. World J Surg (2008) 0.93
Physician follow-up and observation of guidelines in the post treatment surveillance of colorectal cancer. Surgery (2013) 0.88
Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein. BMC Cancer (2006) 0.86
Follow-up recommendations for colon cancer. Clin Colon Rectal Surg (2005) 0.85
Surveillance of patients following surgery with curative intent for colorectal cancer. World J Gastroenterol (2007) 0.85
Selective Use of (18)F-Fluorodeoxyglucose-Positron Emission Tomography and Computed Tomography in the Management of Metastatic Disease from Colorectal Cancer: Results from a regional centre. Sultan Qaboos Univ Med J (2015) 0.83
Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada. Curr Oncol (2015) 0.83
The role of postoperative surveillance in colorectal cancer. Clin Colon Rectal Surg (2007) 0.82
A simulation model of colorectal cancer surveillance and recurrence. BMC Med Inform Decis Mak (2014) 0.79
Effectiveness of adjuvant radiotherapy after local excision of rectal cancer with deep submucosal invasion: a single-hospital, case-control analysis. Surg Endosc (2015) 0.78
Early recurrence in patients undergoing curative surgery for colorectal cancer: is it a predictor for poor overall survival? Int J Colorectal Dis (2013) 0.78
Chest X-ray in the follow-up of renal cell carcinoma. World J Urol (2013) 0.77
Preoperative evaluation and oncologic principles of colon cancer surgery. Clin Colon Rectal Surg (2005) 0.77
Rate of pulmonary metastasis varies with location of rectal cancer in the patients undergoing curative resection. World J Surg (2015) 0.77
Restaging of colorectal cancer and PET/CT. Ulus Cerrahi Derg (2013) 0.75
Post-Resection Surveillance in GI Cancers. Indian J Surg (2013) 0.75
Surveillance and Survivorship after Treatment for Colon Cancer. Clin Colon Rectal Surg (2015) 0.75
The Role of High Frequency Dynamic Threshold (HiDT) Serum Carcinoembryonic Antigen (CEA) Measurements in Colorectal Cancer Surveillance: A (Revisited) Hypothesis Paper. Cancers (Basel) (2011) 0.75
A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer. PLoS One (2016) 0.75
Surveillance for asymptomatic recurrence in resected stage III colon cancer: does it result in a more favorable outcome? J Gastrointest Oncol (2015) 0.75
The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg (1954) 6.74
Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med (1993) 5.00
Value of outpatient follow-up after curative surgery for carcinoma of the large bowel. Br Med J (1980) 4.19
Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum (1988) 2.20
Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet (1992) 2.15
Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg (1994) 1.74
Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer (1985) 1.61
Carcinoma of the colon and rectum in a defined population. An epidemiological, clinical and postmortem investigation of colorectal carcinoma and coexisting benign polyps in Malmö, Sweden. Acta Chir Scand Suppl (1973) 1.52
Colonoscopic surveillance after curative resection for colorectal cancer. Br J Surg (1993) 1.47
Hepatic resection for isolated metastasis from colorectal carcinoma. Am J Surg (1985) 1.46
Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum (1994) 1.41
A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery (1987) 1.35
Follow-up of patients operated on for colorectal carcinoma. Am J Surg (1990) 1.33
Postoperative follow-up of patients with carcinoma of the colon. Mayo Clin Proc (1983) 1.20
Prospective monitoring trial for carcinoma of colon and rectum after surgical resection. Surg Gynecol Obstet (1989) 1.10
Is follow-up of colorectal cancer patients worthwhile? Dis Colon Rectum (1993) 1.02
Colorectal cancer. Principles of postoperative follow-up. Cancer (1992) 0.97
Follow-up plans after treatment of primary colon and rectum cancer. World J Surg (1991) 0.94
Follow-up of patients with colorectal cancer. Am J Surg (1984) 0.91
Hepatic resection for metastatic disease. Can J Surg (1986) 0.90
Benefits of colonoscopic surveillance after curative resection of colorectal cancer. Ann Surg (1994) 0.83
Standard postoperative monitoring of patients after primary resection of colon and rectum cancer. Cancer (1993) 0.82
Follow-up of patients after primary colorectal cancer resection. Semin Surg Oncol (1991) 0.78
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med (2001) 18.77
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57
New knowledge of chlamydiae and the diseases they cause. J Infect Dis (1975) 9.35
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med (2001) 7.59
Role of LXRs in control of lipogenesis. Genes Dev (2000) 6.98
Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran. J Infect Dis (1972) 6.85
Amino acid sequence for the peptide extension on the prolipoprotein of the Escherichia coli outer membrane. Proc Natl Acad Sci U S A (1977) 6.22
Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature (1999) 5.77
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol (2003) 5.71
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA (1993) 5.43
Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med (2001) 5.22
Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A (1998) 4.92
Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol (1999) 4.77
Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell (1999) 4.69
Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials (2005) 4.27
In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus. Nat Med (2000) 4.18
Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science (1993) 3.99
Proximal impact of two first-grade preventive interventions on the early risk behaviors for later substance abuse, depression, and antisocial behavior. Am J Community Psychol (1999) 3.98
Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron (2000) 3.91
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med (1995) 3.83
Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. Cancer Res (1999) 3.79
Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med (2000) 3.72
Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am J Physiol Heart Circ Physiol (2000) 3.32
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med (1994) 3.29
Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. J Am Coll Cardiol (1996) 3.11
Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol (1997) 3.04
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95
Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst (1997) 2.95
Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis. Proc Natl Acad Sci U S A (1999) 2.58
Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut (1996) 2.58
Clinical manifestations and diagnosis of acute pyrethroid poisoning. Arch Toxicol (1989) 2.50
PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet (1997) 2.44
The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J Immunol (1999) 2.44
Regression analysis when covariates are regression parameters of a random effects model for observed longitudinal measurements. Biometrics (2000) 2.37
Differentiation of TRIC and LGV organisms based on enhancement of infectivity by DEAE-dextran in cell culture. J Infect Dis (1972) 2.36
The BioCAT undulator beamline 18ID: a facility for biological non-crystalline diffraction and X-ray absorption spectroscopy at the Advanced Photon Source. J Synchrotron Radiat (2004) 2.31
Cell-free synthesis of a specific lipoprotein of the Escherichia coli outer membrane directed by purified messenger RNA. Proc Natl Acad Sci U S A (1974) 2.30
Cooperative binding of Ets-1 and core binding factor to DNA. Mol Cell Biol (1994) 2.27
Electron beam computed tomographic coronary calcium as a predictor of coronary events: comparison of two protocols. Circulation (1997) 2.24
Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol (1996) 2.21
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. J Nucl Med (2001) 2.20
Evidence of linkage disequilibrium between schizophrenia and the SCa1 CAG repeat on chromosome 6p23. Am J Hum Genet (1996) 2.19
Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet (1996) 2.19
The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet (1992) 2.18
Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development (2000) 2.18
Microsurgical replantation of the avulsed scalp: report of 20 cases. Plast Reconstr Surg (1996) 2.17
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology (1996) 2.16
Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J Biol Chem (1997) 2.10
Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res (1999) 2.09
Retracted CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice. Clin Exp Immunol (2009) 2.06
Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. J Med Chem (2001) 2.06
E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst (2000) 2.05
Dual role of caspase-11 in mediating activation of caspase-1 and caspase-3 under pathological conditions. J Cell Biol (2000) 2.04
Comparison of the NCI open database with seven large chemical structural databases. J Chem Inf Comput Sci (2001) 2.03
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol (1995) 2.02
Purification and characterization of Klebsiella aerogenes UreE protein: a nickel-binding protein that functions in urease metallocenter assembly. Protein Sci (1993) 2.02
A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem (1997) 2.00
The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol (1992) 1.99
Myomegalin is a novel protein of the golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase. J Biol Chem (2000) 1.97
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Ann Oncol (2001) 1.94
Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol (2001) 1.91
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand (2003) 1.90
Chlamydial infection of mothers and their infants. J Pediatr (1979) 1.89
LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest (1998) 1.89
Gaseous pollutants in particulate matter epidemiology: confounders or surrogates? Environ Health Perspect (2001) 1.88
Long term survival after pancreatic resection for pancreatic adenocarcinoma. Am J Gastroenterol (2001) 1.87
Effects of pyrethroid insecticides on subjects engaged in packaging pyrethroids. Br J Ind Med (1988) 1.87
Autosomal XX sex reversal caused by duplication of SOX9. Am J Med Genet (1999) 1.87
Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J Virol (1998) 1.82
Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med (1997) 1.81
Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature (1995) 1.81
Goodness-of-fit for GEE: an example with mental health service utilization. Stat Med (1999) 1.81
Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res (2000) 1.80
A system for characterizing cellular and molecular events in programmed neuronal cell death. J Neurosci (1993) 1.79
Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma. Cancer Res (2001) 1.78
Precision of automatic measurements of pigmented skin lesion parameters with a MelaFind(TM) multispectral digital dermoscope. Melanoma Res (2000) 1.78
unc-8, a DEG/ENaC family member, encodes a subunit of a candidate mechanically gated channel that modulates C. elegans locomotion. Neuron (1997) 1.76
RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am J Transplant (2013) 1.75
Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett (1998) 1.75
Chlamydia trachomatis immunotype J. J Immunol (1975) 1.73
Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest (1998) 1.73
IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J Immunol (1999) 1.73
A PDZ-interacting domain in CFTR is an apical membrane polarization signal. J Clin Invest (1999) 1.73
beta-Catenin associates with the actin-bundling protein fascin in a noncadherin complex. J Cell Biol (1996) 1.70
Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol (1999) 1.70
Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors. Hum Gene Ther (1999) 1.69
Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter. J Neurosci (1999) 1.68
Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation. Exp Neurol (2008) 1.67
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res (2001) 1.67
Hearing preservation in vestibular schwannoma surgery: what factors influence outcome? J Neurosurg (1995) 1.64
Sequence specificity of the core-binding factor. J Virol (1993) 1.63
Isolation of a ribonucleoprotein complex involved in mRNA localization in Drosophila oocytes. J Cell Biol (2000) 1.63
Likelihood models for clustered binary and continuous outcomes: application to developmental toxicology. Biometrics (1999) 1.62
Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J Immunol (1995) 1.62